Clinical trial
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
NCT02391142 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
- Lead sponsor
- First Affiliated Hospital of Harbin Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2014
- Completion date
- January 31, 2019
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.